Greenway Bio Products Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 06-12-2024
- Paid Up Capital ₹ 0.10 M
as on 06-12-2024
- Company Age 10 Year, 12 Days
- Last Filing with ROC 31 Mar 2019
- Revenue %
(FY 2019)
- Profit -9383.67%
(FY 2019)
- Net Worth -63.17%
(FY 2019)
- Total Assets 0.15%
(FY 2019)
About Greenway Bio Products
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Srinivasa Thotakura and Radhakrishnarao Deevi serve as directors at the Company.
- CIN/LLPIN
U24211AP2014PTC095797
- Company No.
095797
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Dec 2014
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Krishna, Andhra Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Greenway Bio Products?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Srinivasa Thotakura  | Director | 09-Dec-2014 | Current |
Radhakrishnarao Deevi  | Director | 09-Dec-2014 | Current |
Financial Performance and Corporate Structure Insights of Greenway Bio Products.
Greenway Bio Products Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 9383.67% decrease in profit. The company's net worth observed a substantial decline by a decrease of 63.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Greenway Bio Products?
In 2019, Greenway Bio Products had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Greenway Building Materials India Private LimitedActive 13 years 5 monthsSrinivasa Thotakura is a mutual person
Greenway Infradevelopers India Private LimitedActive 9 years 5 monthsSrinivasa Thotakura is a mutual person
- Greenway Infratech (India) Private LimitedActive 15 years 11 months
Srinivasa Thotakura is a mutual person
Bhagavati Aerobriks Industries Private LimitedActive 12 years 6 monthsSrinivasa Thotakura is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Greenway Bio Products?
Unlock and access historical data on people associated with Greenway Bio Products, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Greenway Bio Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Greenway Bio Products's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
